WINT: Windtree Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for WINT
Across the 3 sessions after earlier WINT headlines, the stock closed higher 0 times and lower 0 times, with a median move of 0.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WINT | SPY |
|---|---|---|---|
| Nov 17, 2025 | Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee | +0.0% | -0.9% |
| Nov 14, 2025 | Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate | +0.0% | -0.0% |
| Nov 13, 2025 | Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company | +0.0% | -1.7% |
Quantisnow market dataNASDAQ
WINT
Windtree Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for WINT
Full WINT profile on Quantisnow Follow WINT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time